Company / Revenue
Wave Life Sciences Ltd. Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$42.7M
FY2025
5-year range
$20.1M / $113.3M
FY2021-FY2025
Trend
-60.5%
vs FY2024
Sector context
#123 of 155
Health Care
What the data says
Wave Life Sciences Ltd.'s revenue of $43M is lower than 79% of companies in the Health Care sector (FY2025). Revenue has fluctuated over the past 10 years, ranging from $676,000 in FY2017 to $113M in FY2023.
Based on SEC 10-K filings.
$43M in FY2025 with a 5-year CAGR of +21.7%.
Declined from $113M to $43M over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- +1.4%
- 5-Year CAGR
- +21.7%
- 10-Year CAGR
- -
Sector benchmark
Bottom 21% in Health CareTop 79% of 155This company $42.7M Sector average $4.5B
▼
-99.0% below sector average
Key checks
Key Insights
- 5-year CAGR of +21.7%, indicating consistent growth.
- In FY2025, revenue decreased 60.5% year-over-year.
- Ranks #123 out of 155 companies in the Health Care sector.
- Peak revenue was recorded in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $42.7M | -60.5% |
| FY2024 | $108.3M | -4.4% |
| FY2023 | $113.3M | +176.6% |
| FY2022 | $41.0M | +104.0% |
| FY2021 | $20.1M | +25.6% |
| FY2020 | $16.0M | +310.6% |
| FY2019 | $3.9M | -73.0% |
| FY2018 | $14.4M | +2032.2% |
| FY2017 | $676.0K | -54.5% |
| FY2016 | $1.5M | +5611.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026